The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-3-(7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-N-(1-phenylethyl)propanamide ID: ALA3092554
PubChem CID: 136249354
Max Phase: Preclinical
Molecular Formula: C19H18ClN3O2
Molecular Weight: 355.83
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](NC(=O)CCc1nc2cc(Cl)ccc2c(=O)[nH]1)c1ccccc1
Standard InChI: InChI=1S/C19H18ClN3O2/c1-12(13-5-3-2-4-6-13)21-18(24)10-9-17-22-16-11-14(20)7-8-15(16)19(25)23-17/h2-8,11-12H,9-10H2,1H3,(H,21,24)(H,22,23,25)/t12-/m1/s1
Standard InChI Key: OCTUFPUUGSGQDM-GFCCVEGCSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
22.4920 -5.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4908 -6.4903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1989 -6.8993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1971 -5.2619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9057 -5.6672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9091 -6.4924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6215 -6.8998 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3350 -6.4865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3316 -5.6613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.6147 -5.2494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6102 -4.4322 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.0439 -6.8932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7504 -6.4827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4593 -6.8893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1659 -6.4788 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4615 -7.7065 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8747 -6.8855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5813 -6.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2859 -6.8841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9920 -6.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9903 -5.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2765 -5.2497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5733 -5.6618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8769 -7.7027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7828 -6.8983 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
8 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
17 24 1 1
2 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.83Molecular Weight (Monoisotopic): 355.1088AlogP: 3.39#Rotatable Bonds: 5Polar Surface Area: 74.85Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.91CX Basic pKa: 4.52CX LogP: 2.76CX LogD: 2.76Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.74Np Likeness Score: -1.59
References 1. Lindgren AE, Karlberg T, Ekblad T, Spjut S, Thorsell AG, Andersson CD, Nhan TT, Hellsten V, Weigelt J, Linusson A, Schüler H, Elofsson M.. (2013) Chemical probes to study ADP-ribosylation: synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3/PARP3., 56 (23): [PMID:24188023 ] [10.1021/jm401394u ]